Status:
COMPLETED
Troponin Elevation in Acute Ischemic Stroke (TRELAS)
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Stroke
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective of the prospective observational trial TRELAS (TRoponin ELevation in Acute ischemic Stroke) is to elucidate the underlying pathomechanism of cTnT elevation in acute ischemic stro...
Detailed Description
The primary objective of the prospective observational trial TRELAS (TRoponin ELevation in Acute ischemic Stroke) is to elucidate the underlying pathomechanism of cTnT elevation in acute ischemic stro...
Eligibility Criteria
Inclusion
- Acute ischemic stroke, confirmed by cerebral MRI or CT, respectively
- Inclusion within ≤ 72 hours after symptom onset
- hsTroponin T \>0,05 µg/l
Exclusion
- Renal insufficiency (creatinine ≥1,2 mg/dl)
- Limited life expectancy or mRS ≥ 4 prior to stroke event leading to hospital admission
- Contraindications for the coronary angiography
- Age \< 18 years
- Pregnancy
- Patient unwilling or unable to give informed consent
Key Trial Info
Start Date :
February 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2014
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT01263964
Start Date
February 1 2011
End Date
February 1 2014
Last Update
July 21 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Charite Campus Benjamin Franklin
Berlin, Germany, Germany, 12203
2
Charite, Campus Benjamin Franklin
Berlin, State of Berlin, Germany, 12203